Transgenomic to Hold Third Quarter Financial Results Conference Call on November 15, 2010
OMAHA, Neb., November 8, 2010 /PRNewswire-FirstCall/ — Transgenomic, Inc. (OTC Bulletin Board: TBIO) today announced the following Webcast:
Transgenomic, Inc. Third Quarter 2010 Financial Results and What: Business Update Conference Call When: Monday, November 15, 2010 @ 5:00 p.m. Eastern Where: http://www.transgenomic.com/events.asp?id=6 Live over the Internet --Simply log on to the web at the How: address above. Contact: Investor Relations, 402-452-5400
To access the call via telephone, call 888-563-6275 from the U.S. or Canada or 706-643-3137 for international participants and enter conference ID number 24244484. A telephone replay will be available from 6:00 p.m. Eastern Time November 15, 2010 through 11:59 p.m. Eastern Time on November 17, 2010 by dialing 800-642-1687 (domestic) or 706-645-9291 (international) and entering conference ID number 24244484.
About Transgenomic, Inc.
Transgenomic, Inc. (www.transgenomic.com ) is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis, providing products and services in DNA mutation detection and discovery for clinical research, clinical molecular diagnostics and pharmacogenomics analyses. Its product offerings include the WAVEÃ‚® Systems and associated consumables specifically designed for use in genetic variation detection and single- and double-strand DNA/RNA analysis and purification. With broad applicability to genetic research, nearly 1,500 systems have been shipped to customers in more than 50 countries. The SURVEYORÃ‚® Mutation Detection Kits and SURVEYOR Check-It Kit provide reagents and protocols for high sensitivity detection of mutations in DNA. In addition, HANABI automated chromosome harvesting systems improve laboratory productivity with consistent quality compared with manual methods for cytogenetic analyses. Service offerings include the Transgenomic Molecular Laboratory, which provides reference laboratory services specializing in molecular diagnostics including Mitochondrial Disorders, Oncology and Hematology, Molecular Pathology and Inherited Diseases. Transgenomic Pharmacogenomics Services is a CRO for pharmacogenomic, translational research and clinical trials.
SOURCE Transgenomic, Inc.